PROCEPT BioRobotics Corp (PRCT): Market Cap to Revenue

Symbol and logo of brand PROCEPT BioRobotics Corp (PRCT)

PROCEPT BioRobotics is implementing AquaBeam automated platforms for precision tissue removal, expanding its reach through educational alliances with urologists. P/S fluctuations reflect the market valuation of revenue, with the metric holding at 3.80. High barriers to entry are driven by patent protection and significant clinic re-equipment costs, which block customer migration to other providers.

PRCT PROCEPT BioRobotics Corp P/S Multiple (07/04/2022 - 11/13/2026)

Analytical breakdowns for PROCEPT BioRobotics Inc (PRCT)

- share price and consensus valuation forecast:
General company analysis:PRCT procept-biorobotics.com
Core merchandise of PROCEPT BioRobotics

Due to inelastic demand for Aquablation technology and the ability to dictate pricing to clinics, PROCEPT BioRobotics (PRCT) possesses significant pricing power, as reflected in its P/S ratio. This multiple relates market capitalization to annual sales volume, determining the cost of each dollar of revenue. An analysis of the industry-average P/S for the company allows for an assessment of whether the premium for product uniqueness is justified or if the asset is overvalued.

Competitors of PROCEPT BioRobotics

DXCM (dexcom.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Penumbra PEN|NOVT - Market Cap to Revenue|Haemonetics Corp. - P/S Multiple|Price to Sales Inspire Medical Systems Inc|CNMD: P/S Multiple|Market Cap to Revenue Ratio PLSE|INMD (InMode) - P/S Multiple|Picard Medical Corp (PMI) - Price-to-Revenue Coefficient|P/S Multiple SRDX|Market Cap to Revenue Eversense SENS|P/S Multiple NPCE (NeuroPace, Inc.)|P/S Multiple Tactile Systems Technology, Inc. TCMD|SNWV - Price-to-Revenue Ratio|OM: Price-to-Revenue Ratio|ELMD (smartvest.com) - Market Cap to Revenue|LENSAR Inc - Market Capitalization-to-Revenue Ratio|RCEL (AVITA Medical, Inc.) - P/S Multiple|Price to Sales Profound Medical Corporation PROF|Price-to-Revenue Ratio Baird Medical Investment (BDMD)|edap-tms.com (EDAP) - Price-to-Revenue Multiple|Apyx Medical Corporation - Market Cap to Revenue|P/S Multiple IceCure Medical Ltd. ICCM|Pulmonx Corp. - P/S Multiple|Price-to-Revenue Coefficient TELA Bio, Inc. TELA|cytosorbents.com (CTSO) - Price-to-Revenue Ratio|Price-to-Sales Ratio SRTS (Sensus Healthcare Inc)|Price-to-Revenue Ratio Zynex Inc|Market Cap to Revenue electroCore Medical (ECOR)|P/S Multiple RBOT|IINN - Price to Sales|Price-to-Revenue Ratio SeaStar Medical ICU|IRIX: Market Cap to Revenue Ratio|INBS: Market Cap to Revenue|Beyond Air, Inc. - Market Cap to Sales Volume|Profusa Inc (PFSA) - Price-to-Revenue Ratio|Price-to-Sales Ratio SSKN (STRATA Skin Sciences, Inc.)|Price-to-Revenue Ratio GlucoTrack, Inc.|NAOV: Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Venus Concept Corp (VERO)|NUWE - Price to Sales|P/S Multiple AEMD (Aethlon Medical)|ASXC - Market Cap to Revenue|Avinger - P/S Multiple|Price to Sales BioSig|Cutera, Inc (CUTR) - Price-to-Revenue Ratio|Price-to-Sales Ratio KNW (Know Labs Corporation)|Market Cap to Revenue NARI|NVRO (nevro.com) - Market Cap to Sales Volume|Market Cap to Revenue RSLS (ReShape Lifesciences)|SILK (Silk Road Medical, Inc.) - Market Capitalization-to-Revenue Ratio